These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060 [TBL] [Abstract][Full Text] [Related]
4. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells. Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033 [TBL] [Abstract][Full Text] [Related]
6. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma. Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156 [TBL] [Abstract][Full Text] [Related]
7. Genetically Encoded Self-Assembling Iron Oxide Nanoparticles as a Possible Platform for Cancer-Cell Tracking. Efremova MV; Bodea SV; Sigmund F; Semkina A; Westmeyer GG; Abakumov MA Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809789 [TBL] [Abstract][Full Text] [Related]
8. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends. Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012 [TBL] [Abstract][Full Text] [Related]
9. Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma. Zhu X; Zhou H; Liu Y; Wen Y; Wei C; Yu Q; Liu J Acta Biomater; 2018 Dec; 82():143-157. PubMed ID: 30316026 [TBL] [Abstract][Full Text] [Related]
10. Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma. Ag Seleci D; Maurer V; Barlas FB; Porsiel JC; Temel B; Ceylan E; Timur S; Stahl F; Scheper T; Garnweitner G Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925347 [TBL] [Abstract][Full Text] [Related]
11. Indocyanine Green-holo-Transferrin Nanoassemblies for Tumor-Targeted Dual-Modal Imaging and Photothermal Therapy of Glioma. Zhu M; Sheng Z; Jia Y; Hu D; Liu X; Xia X; Liu C; Wang P; Wang X; Zheng H ACS Appl Mater Interfaces; 2017 Nov; 9(45):39249-39258. PubMed ID: 29039909 [TBL] [Abstract][Full Text] [Related]
12. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma. Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632 [TBL] [Abstract][Full Text] [Related]
13. Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells. Wang D; Li Y; Tian Z; Cao R; Yang B Ther Deliv; 2014 May; 5(5):511-24. PubMed ID: 24998271 [TBL] [Abstract][Full Text] [Related]
14. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC Life Sci; 2022 May; 296():120435. PubMed ID: 35247437 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery. Yoon DJ; Kwan BH; Chao FC; Nicolaides TP; Phillips JJ; Lam GY; Mason AB; Weiss WA; Kamei DT Cancer Res; 2010 Jun; 70(11):4520-7. PubMed ID: 20460527 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models. Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
18. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
19. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier. Shi D; Mi G; Shen Y; Webster TJ Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016 [TBL] [Abstract][Full Text] [Related]